178 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
be liable or responsible for any amount in excess of the underwriting discount applicable to the Shares to be purchased by such Underwriter hereunder
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
currency, the agency or organization, if any, responsible for overseeing such composite currency;
the designation of the currency, currencies or currency … to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall send to each securityholder of the securities
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
States dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible … with the indenture. If a Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible
S-3ASR
EX-4.3
w4yy8gpvhps74g4va
2 Jan 24
Automatic shelf registration
4:06pm
S-3ASR
ak0wp
2 Jan 24
Automatic shelf registration
4:06pm
UPLOAD
g7yje
27 Oct 23
Letter from SEC
12:00am
8-K
EX-10.2
c9p3fwl6v3g4
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
hc6xt
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
ekib5w 3ldmk8xom5e
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
0fshvnkayg
29 Sep 23
Prospectus supplement for primary offering
4:51pm